compounding HOTLINE

Pharmacy Times
Volume 0

Mr. Erickson is director of professional affairs at Gallipot Inc.

A patient complained of redness at the site of application of a topical, transdermal (poloxamer-lecithin organogel?based) preparation. The patient applied the same material at the same site over the past 6 months. Suggestions?

Click Here For The Answer ----------->


Generally, patients should be encouraged to rotate sites of application of extemporaneously prepared formulations intended for transdermal administration of active ingredients, particularly when occlusive dressing technique is employed. Consult with the patient about areas where the epidermis is thin and where hair growth is thinnest.

toggle(getObject('exp1048685570_link'), 'exp1048685570');

Recent Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs